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Reprogramming of somatic cells into induced pluripotent stem cells (iPS) or directly
into cells from a different lineage, including neurons, has revolutionized research in
regenerative medicine in recent years. Mesenchymal stem cells are good candidates for
lineage reprogramming and autologous transplantation, since they can be easily isolated
from accessible sources in adult humans, such as bone marrow and dental tissues. Here,
we demonstrate that expression of the transcription factors (TFs) SRY (sex determining
region Y)-box 2 (Sox2), Mammalian achaete-scute homolog 1 (Ascl1), or Neurogenin
2 (Neurog2) is sufficient for reprogramming human umbilical cord mesenchymal stem
cells (hUCMSC) into induced neurons (iNs). Furthermore, the combination of Sox2/Ascl1
or Sox2/Neurog2 is sufficient to reprogram up to 50% of transfected hUCMSCs into
iNs showing electrical properties of mature neurons and establishing synaptic contacts
with co-culture primary neurons. Finally, we show evidence supporting the notion that
different combinations of TFs (Sox2/Ascl1 and Sox2/Neurog2) may induce multiple and
overlapping neuronal phenotypes in lineage-reprogrammed iNs, suggesting that neuronal
fate is determined by a combination of signals involving the TFs used for reprogramming
but also the internal state of the converted cell. Altogether, the data presented here
contribute to the advancement of techniques aiming at obtaining specific neuronal
phenotypes from lineage-converted human somatic cells to treat neurological disorders.
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genes
INTRODUCTION
Reprogramming of somatic cells into induced pluripotent stem cells (iPS) that can generate
all three major embryonic lineages, stem cells and even a new animal has revolutionized
research in regenerative medicine in recent years (Takahashi and Yamanaka, 2006; Okita
et al., 2007). Somatic cells isolated from different sources can be converted into iPS
(Meissner et al., 2007; Aoi et al., 2008; Hanna et al., 2008; Espejel et al., 2010; Imamura
et al., 2010), which in turn can be converted into specific cell types including neurons
(Wernig et al., 2008; Kuzmenkin et al., 2009; Mizuno et al., 2010; Zhang et al., 2013).
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However, generation of iPS and further differentiation into
neuronal cells is time consuming and the cells retain tumorigenic
potential (Takahashi and Yamanaka, 2006; Okita et al., 2007).
In contrast, direct lineage reprogramming of somatic cells is a
fast process and bypasses the pluripotent stage associated with
tumor transformation. Astrocytes isolated from the postnatal
cerebral cortex of mice were the first cells to be directly
reprogrammed into induced neurons (iNs) following expression
of the transcription factor (TF) Neurogenin 2 (Neurog2) or
Mammalian achaete-scute homolog 1 (Mash1/Ascl1) (Berninger
et al., 2007; Heinrich et al., 2011). Subsequently, the list of
murine cell types liable to lineage reprogramming into iNs
grew substantially, including non-neural cells, such as mouse
fibroblasts and hepatocytes (Vierbuchen et al., 2010; Marro et al.,
2011). However, non-neural cells typically require more than one
TF to achieve a full neuronal conversion.
Direct reprogramming of human somatic cells into neurons
can also be achieved through expression of Ascl1 in combination
with other TFs (Ambasudhan et al., 2011; Son et al., 2011;
Karow et al., 2012). It has also been reported that expression
of Ascl1 or Neurog2 alone is sufficient to induce conversion of
human fibroblasts into induced neurons (Chanda et al., 2014;
Gascón et al., 2016), but the efficiency of this process is low
(<10%). Moreover, the phenotypes of iNs obtained through
direct cell lineage reprogramming using human cells remains
largely elusive. Pinpointing strategies capable of producing iNs
exhibiting defined neurochemical phenotypes is a critical step
towards translation of the lineage reprogramming techniques
into clinics.
Here, we show that the expression of the transcription
factor SRY (sex determining region Y)-box 2 (Sox2), Ascl1 or
Neurog2 is sufficient to lineage-convert a small fraction of human
umbilical cord mesenchymal stem cells (hUCMSCs) into iNs. In
contrast, the co-expression of either Sox2/Ascl1 or Sox2/Neurog2
is sufficient to convert a large fraction of hUCMSCs (up
to 50%) into iNs displaying electrophysiological hallmarks of
mature neurons and establishing synaptic contacts with other
cells. Furthermore, we show that iNs may express transcripts
associated with the acquisition of different neurochemical
phenotypes, independently of the combination of transcription
factors used. Also, Sox2/Ascl1 and Sox2/Neurog2 may induce
the expression of genes involved in the acquisition of the
same neurochemical phenotypes, suggesting that iNs fate
during lineage-conversion is influenced by other aspects
than the transcription factors used. Collectively, our data
indicate that hUCMSCs are good candidates for lineage
reprogramming into iNs, but more studies are required to further
advance protocols capable of producing iNs with a particular
phenotype.
MATERIALS AND METHODS
Cell Culture
Human multipotent mesenchymal stem cells (hMSC) were
isolated from umbilical cords donated with informed consent
of the pregnant mothers at maternity Januário Cicco, Federal
University of Rio Grande do Norte, Natal, Brazil. The study
was approved by the Research Ethics Committee of the Federal
University of Rio Grande do Norte (Project Number 508.459),
and in strict agreement with Brazilian law (Resolution 196/96).
All subjects gave written informed consent in accordance with
the Declaration of Helsinki.
In this study, Wharton’s jelly mesenchymal stem cells were
isolated from umbilical cord. Following isolation from the
subendothelium vein, according to the method previously
published (Duarte et al., 2012), the remaining umbilical cord
tissue was cut in small pieces and washed with phosphate-
buffered saline (PBS; 137mM NaCl, 2.7mM KCl, 4.3mM
Na2HPO4, and 1.47mM KH2PO4; Merck), supplemented with
3% antibiotic–antimycotic solution (prepared with 10,000
units/ml penicillin G sodium, 10,000µg/ml streptomycin sulfate
and 25µg/ml amphotericin B; HyClone). Then, the tissue was
centrifuged at 200 g for 10min, and the pellet resuspended in
10mL of 0.1% collagenase type IV (Worthington) diluted in
PBS. After that, the explants were incubated for 16 h at 37◦C
in a water bath. The tissue was centrifuged again at 200 g
for 10min, the pellet washed twice with PBS and then gently
dissociated in a digestion solution containing 0.25% trypsin and
0.02% EDTA (Invitrogen) for 15min at room temperature. To
interrupt trypsin activity, we added fetal bovine serum (FBS;
HyClone). Once again, the cell suspension was centrifuged,
and the cell pellet resuspended in minimum essential medium
a (α MEM; Gibco Invitrogen) supplemented with 10% FBS
and 1% antibiotic solution. Cells were plated onto T25 tissue
culture flasks (TPP) and these cultures maintained at 37◦C in
a humidified atmosphere containing 5% CO2. After 2 or 4
days, the medium was changed and non-adherent cells were
removed. Cultures consisting of small, adherent and spindle
shaped fibroblastoid cells reaching 60–70% of confluence were
detached and subcultured at 4,000 cells/cm2.
Characterization of hMSCs
The cells isolated from Wharton’s jelly human umbilical cord
were characterized as MSCs, according to the criteria proposed
by the International Society for Cellular Therapy (Horwitz et al.,
2005; Dominici et al., 2006). The hMSCs were labeled with
a panel of monoclonal antibodies against several cell markers,
including CD105-FITC, CD90PE-Cy5 (Bioscience), CD73PE,
CD34PE, HLA-DR-FITC, CD45-FITC, and CD14PE (Becton
Dickinson’s). Briefly, the cells were detached of the tissue culture
plates using 0.25% trypsin/EDTA, washed, and homogenized
with PBS. They were then incubated with monoclonal antibody
for 30min in darkness at room temperature. At the end of
this period, the cell suspension was centrifuged, washed in PBS,
and re-suspended in cold fixing solution, 0.5% formaldehyde
in PBS. For each test, isotype-matched monoclonal antibodies
were used as negative controls (IgG1-FITC, PE, and PE-Cy5;
Becton Dickinson’s). The fluorescence intensity of labeled cells
was determined with a fluorescence-activated cell analyzer
(FACScan) using cell quest software (Cell QuestTM Software,
Becton Dickinson Immunocytometry Systems), a total of
20,000 events for each sample were recorded. The following
parameters were considered: forward scatter in linear scale
(which evaluates cell size), side scatter in linear scale (assessing
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cell complexity), and cell marker expression in fluorescence
analysis by FL1, FL2, and FL3 in logarithmical scale, representing
the antigen–antibody reaction conjugated to FITC, PE, and PE-
Cy5, respectively. Results were expressed as a percentage of cells
labeled with monoclonal antibodies. Osteogenic, adipogenic, and
chondrogenic differentiation assays were carried out according to
methodology previously published (Duarte et al., 2012).
Plasmids
The pro-neural genes Ascl1, Neurog2, or Sox2 were expressed
under control of an internal chicken β-actin promoter with
cytomegalovirus enhancer (pCAG) together with DsRed or GFP
behind an internal ribosomal entry site (pCAG-Ascl1-IRES-
DsRed, pCAG-Neurog2-IRES-DsRed, and pCAG-Sox2-IRES-
GFP). For control experiments, cultures were transfected with
plasmids encoding only DsRed or GFP (pCAG-IRES-DsRed or
pCAG-IRES-GFP) (Heinrich et al., 2010; Karow et al., 2012).
Plasmid stocks were prepared in Escherichia coli and purified
using the endotoxin-free Maxiprep plasmid kit (Invitrogen).
DNA concentration was adjusted to 1 µg/µL in TE buffer
endotoxin free, and plasmids were stored at−20◦C.
Transfection
For transfections, hMSC were seeded in 24-well plates onto
poly-D-lysine (Sigma-Aldrich) and laminin (L-2020; Sigma
Aldrich) coated glass coverslips at a density of 3 × 104
cells per well in 0.5mL α MEM (Gibco) supplemented with
10% fetal bovine serum (FBS) and 1% antibiotic solution
(penicillin/streptomycin). The cells were grown in these
conditions for 1–3 days until 70–80% confluent.
Both DNA plasmids (1 µg/µL) and a lipophilic cationic
reagent (Lipofectamine 2000, Invitrogen) were diluted in 50
µL Opti-MEM (Reduced Serum Medium, Invitrogen). Mixtures
were incubated for 5min and then combined for a further 20min
according to the manufacturer’s instructions. Complexes were
added to the cells in a total volume of 0.5mL Opti-MEM (Gibco)
and incubated at 37◦C in a humidified atmosphere containing
5% CO2 for 10–12 h. Antibiotics and serum were not used during
transfection procedures.
Co-culture With Hippocampal Neurons
For co-culture experiments, mouse hippocampus at postnatal
day 0 to 4 (P0-4) were dissected in ice-cold PBS and dissociated
in a the digestion solution for 10min at 37◦C. Trypsin
action was interrupted with fetal bovine serum and the tissue
dissociated mechanically with a fire-polished glass Pasteur
pipette. The suspension was then centrifuged at 200 g for 5min
and washed twice in DMEM/F12 10% FBS in DMEM/F12
medium (Gibco). Mouse hippocampal cells were added to the
human cultures 1–2 days after transfection at a density of
50,000 cells per well. The local University Animal Care and
Use Committee (CEUA/UFRN) approved experiments involving
mice. All experiments were carried out in accordance with
international guidelines and regulations for animal use.
Immunocytochemistry
Cell cultures were fixed in 4% paraformaldehyde (PFA) in
PBS for 15min at room temperature. Primary antibodies were
diluted in PBS, 0.5% Triton X-100 and 5% normal goat
serum. Specimens were incubated overnight at 4◦C. After three
washes with PBS, cells were incubated with species-specific
secondary antibodies conjugated to fluorophores for 2 h at
room temperature. Once again, samples were washed with PBS
three times. For nuclei staining, cells were incubated for 5min
with 0.1µg/mL DAPI (4′6′-diamino-2-phenylindone) in PBS
0.1M. Coverslips were finally mounted onto a glass slide with
a mounting medium (Aqua Poly/Mount; Polysciences). The
following primary antibodies and dilutions were used: chicken
anti-Green Fluorescent Protein (GFP, Aves Labs, 1:1,000), rabbit
anti-Red Fluorescent Protein (RFP, Rockland, 1:1,000), mouse
anti-majormicrotubule associated protein (MAP2; Sigma, 1:500),
guinea pig polyclonal anti-vesicular GABA transporter (vGAT,
Synaptic Systems, 1:200), and polyclonal anti-vesicular glutamate
transporter 1 (vGLUT11, Synaptic Systems, 1:1,000).
Electrophysiology
Cell cultures with induced neurons were transferred to a
recording chamber mounted on the stage of a microscope
equipped with a water immersion 40X objective (Zeiss Examiner.
A1, 1 NA) and perfused with oxygenated external solution (1–
1.25 ml/min) at 37◦C. Data were acquired using a patch-clamp
amplifier Axopatch 200B (Molecular Devices) in current or
voltage clamp mode, a 16-bit data acquisition card (National
Instruments), and WinWCP or WinEDR software implemented
by Dr. John Dempster (University of Strathclyde). Patch-pipettes
of borosilicate glass capillaries (GC150F-10 Harvard Apparatus)
were pulled on a vertical puller (Narishige) with resistances from
5–7 M. Pipettes were filled with internal solution (∼290 Osm)
containing (in mM) 130 K+-gluconate, 7 NaCl, 0.1 EGTA, 0.3
MgCl2, 0.8 CaCl2, 2 Mg-ATP, 0.5 NaGTP, 10 HEPES, and 2 EGTA
(pH 7.2 adjusted with KOH 1M). The external solution (∼300
Osm) contained (in mM) 120 NaCl, 3 KCl, 1.2 MgCl2, 2.5 CaCl2,
23 NaHCO3, 5 HEPES, and 11 Glucose (pH 7.4 adjusted with
NaOH 1M).
Patch-clamped cells were measured for input resistance,
resting membrane potential, and capacitance. Recordings were
analyzed with custom routines in MATLAB. Action potentials
were triggered by 400-ms depolarizing current injections from
100 pA, 400ms, with 10 pA increments. The first fired action
potential in response to minimal current injection was analyzed
for amplitude (peak to afterhyperpolarization voltage), half-
width (halfway between threshold voltage and peak), and
afterhyperpolarization amplitude (threshold to minimum of
voltage trough between the first and the second action
potential in a spike train). Instantaneous and steady-state
voltage were analyzed in response to hyperpolarizing current
injections (−100 pA, 400ms). Excitatory postsynaptic currents
were analyzed for amplitude and rise time in free-run traces
of 150 s. Active and passive electrophysiological membrane
properties, including action potential parameters were analyzed
using a Student’s unpaired, two-tailed t-test.
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Calcium Imaging
Calcium imaging was performed on human MSC 3 weeks
post-transfection using Oregon green 488 BAPTA-1 (Invitrogen,
10µM). Imaging was performed in physiological saline solution
containing (in mM) 140 NaCl, 5 KCl, 2 MgCl2, 2 CaCl2, 10
HEPES, 10 glucose, and 6 sucrose (pH 7.35). Images were
acquired approximately every 10ms using a scientific CMOS
camera (Andor). The microscope was controlled by Micro-
Manager software together with the image processor ImageJ.
Changes in fluorescence were measured for individual cells and
average of the first 10 time-lapse images for each region of interest
(ROI) was defined as initial fluorescence (F0).
Single Cell RT-qPCR
After electrophysiological recordings, the cell was sucked
into the recording pipette. Pipettes were quickly removed
and broken into 1.5mL tubes containing 20U of RNase
inhibitor and 8.3mM DTT. Samples were frozen immediately
on dry ice and stored at −80◦C. Immediately after thaw,
the samples were treated to eliminate contaminating DNA
molecules. Complementary DNA (cDNA) synthesis and pre-
amplified reactions were performed with the RT2 PreAMP
cDNA Synthesis Kit following the manufacturer’s procedure
(QIAGEN). Amplification was performed on the Applied
Biosystems ViiA 7 Real-Time PCR (Applied Biosystems).
RT2 Profiler PCR Array were customized in 96-well plates,
designed for analyzing the expression of the following genes:
Choline O-acetyltransferase (CHAT), Tyrosine hydroxylase
(TH), Tryptophan hydroxylase 2 (TPH2), Vesicular glutamate
transporter 1 (VGLUT1 or SLC17A7), GABA Vesicular
transporter (VGAT or SLC32A1), FEZ family zinc finger 2
(FEZF2), T-box brain 1 (TBR1), SATB homeobox 2 (SATB2),
COUP-TF-interacting protein 2 (CTIP2 or BCL11B), Platelet-
derived growth factor receptor, beta polypeptide (PDGFRB),
Thy-1 cell surface antigen (THY-1), Atonal homolog 8 (ATOH8),
Neurogenic differentiation 1 (NEUROD1), Glyceraldehyde-
3-phosphate dehydrogenase (GAPDH), and Hypoxanthine
phosphoribosyltransferase 1 (HPRT1). The RT-qPCR was
performed using the RT2 profiler PCR customized array
(QIAGEN). Each array included genomic DNA control primer
set, reverse transcription control, positive PCR control to report
the efficiency of the polymerase chain reaction itself, and the
endogenous reference genes GAPDH and HPRT1.
Analysis of Single-Cell RT-qPCR
A single-cell RT-qPCR pre-processing was performed based on
method described by Ståhlberg et al. (2013). Melting curve
analysis performed elimination of false positives. Next, relative
quantities were calculated using a cycle of quantification cutoff
(Cq-cutoff) and relative-quantities of cDNA molecule equation.
Missing data were imputed with absolute value 0.5, followed
by conversion to log2-scale. Mean center and auto scale, for
each gene mean center and auto scale were calculated separately
using log2-values. Heat map and Principal Component Analysis
(PCA) were used to visualize expression differences between
groups. Statistical analysis and plotting were performed using the
software R version 3.3.3.
Statistical Analysis
All statistical data are presented as the mean ± standard error
of the mean (SEM) of at least three independent experiments.
Statistically significant differences were assessed by Student’s
unpaired t-test or one-way Analysis of variance (ANOVA),
comparing two or more groups, respectively. P < 0.05 was
considered a significant difference (∗).
RESULTS
Direct Lineage Reprogramming of Human
Umbilical Cord MSCs
Mesenchymal stem cells (MSCs) can be isolated from different
sources in adult humans, including the bone marrow and
umbilical cord (Ding et al., 2011). These cells are highly
plastic, retaining the potential to generate chondroblasts,
adipocytes, and osteoblasts (Caplan, 1991; Dominici et al.,
2006; Afanasyev et al., 2010; Keating, 2012). In order to
characterize the cells isolated from Wharton’s jelly umbilical
cord, we first evaluated the expression of MSC-specific
antigens using flow cytometry. Virtually all cells exhibited
expression of CD105, CD73, and CD90 markers, and lacked
the expression of hematopoietic lineage markers, such as
CD14, CD34, and CD45 (Supplementary Figures 1A–I). The
MSCs also demonstrated capacity for osteogenic, adipogenic,
and chondrogenic differentiation (Supplementary Figures 1J–
L). Given this versatility, we hypothesized that expression
of neurogenic transcription factors in MSCs could directly
reprogram these cells into neurons. To test this possibility,
we transfected plasmids carrying the genes encoding for Sox2,
Neurog2, or Ascl1 into human umbilical cord mesenchymal stem
cells (hUCMSCs) using lipophilic cationic reagent. To monitor
transduced cells, all vectors carried a fluorescent protein (GFP
or DsRed) under control of an internal chicken β-actin promoter
with cytomegalovirus enhancer (pCAG). Vectors expressing GFP
or DsRed alone were used as control (Figures 1A,B). One day
after transfection, cultured medium of hUCMSCs was replaced
with neuronal differentiation medium containing B27. In this
medium, most transfected hUCMSCs underwent cell death
precluding analysis of lineage reprogramming (Supplementary
Figure 2). To overcome this limitation, we co-cultured neonatal
mouse hippocampal cells with hUCMSCs. We found an average
of about 50% GFP+/DsRed+ hUCMSC per field 15 days
after transfection and in the presence of co-cultured neonatal
mouse hippocampal cells. In contrast, the average number of
GFP+/DsRed+ hUCMSCs in the absence of co-cultured cells
was<4% (Supplementary Figure 2). Low number of cells was also
observed in Hucmsc cultures transfected with control plasmids,
indicating that the cell death under these culture conditions
was independent of lineage-reprogramming. It is likely that
the withdrawal of serum performed after transfection (aiming
at the differentiation of induced neurons) affects the survival
of hUCMSCs, whereas addition of co-cultured cells, somehow,
counteracts this cell-death effect. We, therefore, concluded that
co-cultures are necessary to support hUCMSC in the culture
conditions used.
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FIGURE 1 | Direct lineage reprogramming of hUCMSC into iN by forced expression of Sox2, Ascl1, or Neurog2 alone, Sox2/Ascl1 or Sox2/Neurog2. (A–U)
Immunostaining for DSRED (red), GFP (green), MAP2 (white), and DAPI (blue), 15 days post transfection (dpt). Scale bar represents 20µm. (A–D) Example of
hUCMSC transfected with control plasmids encoding only reporter proteins GFP and DSRED. Note that cell displayed classical mesenchymal cell morphologies and
did not express MAP2. (E–H) Example of hUCMSC transfected with Sox2 and Ascl1 (white arrows indicate hippocampal neurons expressing MAP2). (I–L) hUCMSC
transfected with Sox2 and Neurog2. (M–O) hUCMSC transfected with only Sox2. (P–R) hMSC transfected with only Neurog2. (S–U) hUCMSC transfected with only
Ascl1. (V) Histograms show the percentage of induced neurons, measured by the number of expressing MAP2 cells over the total number of reporter positive cells.
Data are presented as mean ± s.e.m. from three independent experiments. ANOVA followed by Dunn’s post-hoc test, *p < 0.05; no statistically significant difference
(n.s.). hUCMSC transfected with control plasmids did not express MAP2, thereby the bar is not being shown.
A few days after transfection, we observed that some
hUCMSCs transfected with proneural genes acquired neuronal-
like morphology. To confirm this possible lineage conversion
of hUCMSCs into iNs, we further analyzed the expression of
the neuronal-specific microtubule-associate protein 2 (MAP2)
15 days after transfection with proneural genes (Figure 1). A
fraction of cells transfected with proneural genes expressed
MAP2 and acquired small-round cell bodies and thin and
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FIGURE 2 | After transfection, cells were grown on astrocyte monolayers which provide support to hUCMSCs-derived iNs. (A–C) hUCMSCs transfected with control,
(D–F) Sox2/Ascl1, or (G–I) Sox2/Neurog2. (J) Histogram shows the percentage of hUCMSCs-derived iNs. Data are presented as mean ± s.e.m. from three
independent experiments, Student’s unpaired t-test, no statistically significant difference (n.s.). hUCMSC transfected with control plasmids were not reprogramed into
induced neurons, therefore the bar is not being shown.
long processes, resembling immature neurons. Whereas,
hUCMSCs transfected with control plasmids displayed classical
mesenchymal cell morphologies and did not express MAP2
(Figures 1A–U). Expression of Sox2, Ascl1, or Neurog2 alone
was sufficient to reprogram hUCMSCs into iNs, albeit at low
rates (Figure 1V). However, the combination of Sox2 and Ascl1
increased the efficiency of reprogramming up to 49%, whereas
the combination of Sox2 and Neurog2 increased the efficiency up
to 35% (Figure 1V). We obtained these results using Wharton’s
jelly mesenchymal stem cells isolated from tree different donors
and did not observed any heterogeneity in the potential of
reprogramming (data not shown). These data indicate that single
proneural TFs have potential to elicit lineage reprogramming
of hUCMSCs into iNs, but that the synergistic action of the
TFs Sox2/Ascl1 or Sox2/Neurog2 is sufficient to induce neuronal
phenotype in a high number of hUCMSCs.
It has been shown that cells from the mesenchymal lineage
can fuse with other cell types in culture (Terada et al., 2002;
Alvarez-Dolado et al., 2003). To rule out the possibility that
hUCMSCs could be fusing with mouse hippocampal neurons
present in our co-cultures, we performed similar experiments
co-culturing reprogrammed hUCMSCs with purified postnatal
mouse cortical astrocytes (Heinrich et al., 2011). Similar to
cultures containing neonatal hippocampal cells, we observed
that hUCMSCs transfected with Sox2/Ascl1 or Sox2/Neurog2
survived in astrocyte monolayers and acquired neuronal-like
morphologies (Figures 2A–I). Thus, lineage reprogramming of
hUCMSCs into iN after Sox2/Ascl1 or Sox2/Neurog2 expression
is unlikely to be attributed to cell fusion with primary co-cultured
neurons. However, we observed a lower lineage conversion
efficiency when plating hUCMSCs on astrocytes (Figure 2J)
compared to hippocampal cells suggesting that additional
factors released by co-cultured neurons may affect either the
reprogramming efficiency or survival of iNs.
Functional Properties of Induced Neurons
To investigate if iNs could establish synaptic connections with
neighboring neurons, we studied the dynamics of calcium
transients using calcium sensitive dye imaging (Rosenberg
and Spitzer, 2011). We measured the spontaneous changes in
fluorescence intensity (1F/F0) during the total period of imaging
(17 s) and compared their responses with primary murine
hippocampal neurons. We found that both human iNs and
mouse hippocampal neurons present in the co-culture displayed
fast calcium-transients as indicated by rapid variations in the
fluorescence (Figures 3A–I, SupplementaryMovies 1, 2). The iNs
reprogrammed with Sox2/Ascl1, Sox2/Neurog2, and the mouse
hippocampal neurons showed a mean variation in fluorescence
intensity of 39.66% (Figure 3J, gray bar), 33.05% (Figure 3J, blue
bar), of 60.83% (Figure 3J, white bar), respectively. In contrast,
the change in fluorescence intensity observed in hUCMSCs
transfected with control plasmids presented a mean value of
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FIGURE 3 | Human MSC lineage-converted iNs show fast calcium transients. (A,B) hUCMSCs transfected with control plasmids encoding only reporter proteins GFP
and DSRED 23 dpt (yellow arrow). (D,E) hUCMSCs transfected with Sox2 and Neurog2 with neuronal morphology 23 dpt (yellow arrow). (G,H) Example of hUCMSCs
transfected with Sox2 and Ascl1 with neuronal morphology 23 dpt (yellow arrow). Note the presence of mouse hippocampal neurons (green arrowheads) in the same
fields. (C,F,I) Representative traces of time course calcium-transients of transfected hUCMSCs are shown by spontaneous variations in the fluorescence intensity (FI).
(J) Histograms show the mean change in fluorescence of mouse hippocampal neurons and iNs. Responses were calculated as the change in fluorescence (1F) over
the initial fluorescence (F0). Number of cells analyzed is indicated in the bars for each group. (ANOVA followed by Tukey’s post-hoc test, *p < 0.05; **p < 0.01;
***p < 0.001).
1.1% (Figure 3J, black bar), significantly lower than the responses
observed in iNs and hippocampal neurons (ANOVA followed
by Tukey’s post-test, p < 0.0001). These observations indicate
that hUCMSCs-derived iNs present fast calcium transients
qualitatively similar of those observed in primary neurons.
Notably, this sudden increase in fluorescence intensity in
hUCMSC-derived iNs was temporally synchronized mouse
hippocampal neurons in the same field of observation
(Figures 4A–I). To quantify this phenomenon, we measured
the percentage of hippocampal neurons showing elevation
in the fluorescence intensity within a time-range (ms) of the
fluorescence fluctuation observed in a single iN within the same
field of observation. The time of the iN calcium transient was
considered as t = 0. We found that the majority of mouse
hippocampal neurons showed changes in fluorescence intensity
within 15ms of fluctuations observed in iNs (Figure 4J),
indicating a strong synchronization of calcium transients
among primary neurons and iNs. Such a strong synchronization
within the frame of milliseconds may suggest that cells are
synaptically connected (Dawitz et al., 2011). To further confirm
that hUCMSCs-derived iNs could receive synaptic inputs, we
performed patch clamp recordings on these cells.
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FIGURE 4 | Synchronization of calcium transients between iNs and primary neurons. (A,D,G) Photomicrographs show hUCMSC cultures 23 dpt and labeled with
BAPTA Oregon Green. Colored circles delimit the regions of interest (ROI) where fluorescence intensity (FI) was measured (colored arrowheads). (B,E,H)
Photomicrographs of the same fields show DsRed expression. Yellow arrowheads (A,B, D,E) point to hUCMSC-derived iNs. Blue, red, green and purple arrowheads
point to primary hippocampal neurons. (C,F,I) Graphics show spontaneous calcium transients. The color of ROIs in the left panel (A,D,G) corresponds to the color of
each trace in the right panel (C,F,I). The traces show spontaneous variations in the FI during 17s of recording. (J) Histogram shows percentage of hippocampal
neurons that respond within a range time difference (ms) in the same area, t=0 was considered the time of spontaneous calcium responses of the reprogrammed iN
present in the same field of imaging. Density curve is represented in black.
We performed patch-clamp recordings on iNs reprogrammed
with one transcription factor (1 TF; n = 5) and compared their
active and passive properties to cells reprogrammed with two
transcription factors (2 TF; n = 10). Cells with 1 TF had a mean
input resistance of 726 ± 119 M, resting membrane potential
of −61 ± 2mV and capacitance of 22 ± 2 pF. Out of the 5
cells, 2 responded with regular spiking pattern (Figure 5A, top
left), 1 responded with startle onset (Figure 5A, top right), and
2 with a spikelet in response to depolarizing current injections
(0–100 pA, 400ms, with 10 pA increments). Spikes were analyzed
for action potential amplitude, action potential half-width and
afterhyperpolarization amplitude. Spikes of cells with 1 TF had
a mean action potential amplitude of 44± 8mV, action potential
half-width of 13 ± 0.5ms and afterhyperpolarization amplitude
of −6 ± 2mV (Figure 5C). In comparison, cells reprogrammed
with 2 TF had a mean input resistance of 605 ± 110 M
(p= 0.51), restingmembrane potential of−59± 2mV (p= 0.54)
and capacitance of 26 ± 1 pF (p = 0.13). Of the 10 cells with 2
TF, 6 responded with regular spiking pattern and 4 responded
with startle onset (0–100 pA, 400ms, with 10 pA increments).
Spikes of cells with 2 TF had a mean action potential amplitude
of 76 ± 3mV (p = 0.0004), action potential half-width of 4 ±
1ms (p = 0.0006) and afterhyperpolarization amplitude of −11
± 2mV (p = 0.22; Figure 5B). While hyperpolarizing current
injections (0 to−100 pA, 400ms, with 10 pA decrements) caused
some cells to rebound (n = 3), prominent membrane sags
could only be detected in cells transfected with Sox2/Neurog2
(n= 7; Figure 5B, right) suggesting that these cells have a sizeable
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hyperpolarization-activated current. Comparing instantaneous
and steady state voltage in response to negative current injections
(−100 pA, 400ms) showed a significant difference between
instantaneous (−71 ± 2mV) and steady state (−66 ± 1mV)
values (p= 0.0427).
We also observed spontaneous excitatory postsynaptic
currents (EPSCs) in iN during voltage clamp (Figure 5D),
suggesting that lineage-reprogrammed iNs could receive synaptic
contacts from other neurons.We compared the first 100 events of
1 TF cells and 2 TF cells against each other. Postsynaptic currents
of cells with 1 TF had an amplitude of 82 ± 9.7 pA and rise time
of 11 ± 0.4ms. The postsynaptic currents of cells with 2 TF had
an amplitude of 86 ± 15.1 pA (p = 0.8312) and a mean rise time
of 9± 0.3ms (p= 0.0211).
Sox2/Neurog2 and Sox2/Ascl1 Induce
Different Neuronal Phenotypes in
hUCMSCs
Next, we set out to evaluate the expression of messenger
RNAs (mRNA) of genes commonly expressed in either hMSCs
or neurons. To that, we collected single cells using a glass-
micropipette, isolated the total mRNA, reverse transcribed,
and pre-amplified cDNAs that were used in RT-qPCR
reactions. We observed that the average expression level of
common MSCs genes THY1 and PDGFB was decreased in
the iNs (Supplementary Figure 3A), whereas the expression
of the neuronal genes ATHO8 or NEUROD1 increased after
expression of Sox2/Ascl1 or Sox2/Neurog2 in hMSCs, respectively
(Supplementary Figure 3B). Combined with our previous
observations, these data indicate that hMSCs were effectively
converted into iNs by forced expression of proneural TFs.
To evaluate the possible phenotypes adopted by hMSC-
derived iNs, we analysed the expression of known genes
expressed by cholinergic (CHAT), dopaminergic (TH),
serotoninergic (TPH2), glutamatergic (SLC17A7), and
GABAergic (SLC32A1) neurons, as well as genes encoding
for transcription factors associated with specific classes of
glutamatergic neurons within the cerebral cortex (FEZF2
and BCL11B—corticofugal neurons; TBR1—cortico-thalamic
neurons; SATB2—callosal neurons). Relative expression of
these transcripts was calculated using a cycle of quantification
cutoff (Cq-cutoff) and relative-quantities of cDNA molecule
equation (Ståhlberg et al., 2013). Next, we used unsupervised
PCA analysis to classify iNs obtained from hUCMSCs expressing
either Sox2/Neurog2 or Sox2/Ascl1. We observed that the
expression levels of the transcripts for CHAT, TH, TPH2,
SLC17A7, SLC32A1, FEZF2, BCL11B, TBR1, and SATB2
could not clearly distinguish the two populations of cells
(Figure 6A), indicating that similar genes were regulated
by both combinations of TFs in hUCMSCs-derived iNs.
Indeed, we observed that both Sox2/Ascl1 and Sox2/Neurog2
could induce the expression of genes associated with distinct
neurochemical phenotypes in hUCMSCs-derived iNs, although
some phenotypes were more commonly observed for a given
TF combination. For instance, Sox2/Ascl1 generated more iNs
expressing high levels of TPH2, whereas Sox2/Neurog2 generated
more CHAT expressing iNs. Nevertheless, the expression of
all transcripts analyzed was regulated by both combinations of
TFs, suggesting that Ascl1 and Neurog2 do not have a unique
role in the phenotypic specification of lineage reprogrammed
hUCMSC-derived iNs (Figure 6B). These data suggest that
the expression of Sox2/Ascl1 or Sox2/Neurog2 in hUCMSC
activates a transcriptional program associated with loss of
mesenchymal phenotype and acquisition of multiple neuronal
phenotypes.
To further evaluate the neurochemical phenotypes of
hUCMSC-derived iNs, we investigated the expression of
SLC17A7 (Vesicular Glutamate Transporter 1 or VGLUT1)
and SLC32A1 (GABA Vesicular Transporter or VGAT) using
immunocytochemistry (Figure 7). We observed that only a
few Sox2/Ascl1-derived iNs showed expression of VGAT fifteen
days after reprogramming (Figures 7I–L), whereas most of the
hUCMSC-derived iNs did not express any of these markers days
after (Figures 7M–Y). Although iNs expressed MAP2 15 days
after transfection with proneural genes (Figure 1), expression
of vesicular neurotransmitter transporters is likely to occur at
later stages of neuronal differentiation. Further analyses and
immunostaining for other vesicular transporters isoforms are
necessary to confirm the phenotypes of hUCMSCs-derived
iNs.
DISCUSSION
Direct lineage reprogramming of human somatic cells into
neurons is a promising strategy to advance cell-based therapies
to treat neurological disorders, as well as to study the basic
mechanisms of neuronal differentiation. In this work, we further
expand the list of cells suitable for direct lineage reprogramming
using transcription factors. More importantly, we show that
combined expression of either Neurog2/Sox2 or Ascl1/Sox2
is sufficient to convert human MSCs into iNs displaying
electrophysiological properties typical of neuronal cells. Finally,
we show that these two combinations of transcription factors
may elicit diverse and non-exclusive neuronal phenotypes in
reprogrammed cells.
Human MSCs are versatile cells, capable of differentiation
into adipocytes, chondrocytes, and osteoblasts (Horwitz et al.,
2005; Dominici et al., 2006). This potential, combined with
the fact that hMSC can be easily isolated from adult donors,
has encouraged researchers to further exploit the versatility of
reprogramming MSCs to other lineages, such as muscle and
neural cells for therapeutic purposes (Fan et al., 2011; Kwon
et al., 2016). However, the capacity to convert MSCs into fully
functional neurons using extrinsic signals remains a matter of
intense debate.
Here, we show that forced expression of Ascl1, Neurog2, or
Sox2 alone is sufficient to convert hUCMSCs into iNs expressing
key neuronal proteins and exhibiting electrophysiological
properties of mature neurons. Importantly, combination of
Neurog2 or Ascl1 with Sox2 significantly increases the rate of
hUCMSC conversion into iNs (up to 35%with Sox2/Neurog2 and
49% with Sox2/Ascl1). This efficiency is similar to the conversion
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FIGURE 5 | hUCMSCs-derived iNs show electrical properties of mature neurons and establish synaptic contacts with co-culture mouse primary neurons.
Electrophysiological properties of cells reprogrammed with one transcription factor (1 TF) compared to cells reprogrammed with two transcription factors (2 TF).
(A) Current clamp traces from cells with 1 TF (left: Ascl11; right: Neurog2) showing regular spiking pattern (left), and startle onset (right) in response to depolarizing
(Continued)
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FIGURE 5 | current injections [50 pA (black), 100 pA (red), 400ms]. (B) Example of current clamp traces from cells with 2 TF (left: Sox2/Ascl1; right: Sox2/Neurog2)
responding with a regular spiking pattern (black: 50 pA; red: 100pA; 400ms). Note that hyperpolarizing current injections caused some cells to rebound (−50 and
−100pA, 400ms). Fluorescence images of the recorded cells are displayed below. (C) Bar graphs showing mean and SEM input resistance, resting membrane
potential and capacitance (top) as well as mean action potential (AP) amplitude, AP half-width and afterhyperpolarization (AHP) amplitude (bottom) for cells with 1 TF
(white bars) and 2 TF (black bars) respectively (Student’s unpaired t-test, ***p < 0.001). (D) Example of voltage clamp trace (free run) showing spontaneous EPSCs of
a reprogramed 1TF iN (top, left) and a 2TF iN (bottom, left). Single postsynaptic currents are plot in gray (right) and the corresponding mean trace is shown in black
(n = 25).
FIGURE 6 | Phenotypic specification of lineage reprogrammed hUCMSC-derived iNs. (A) Principal component analysis (PCA) of gene expression among cells
reprogrammed with Sox2/Neurog2 or Sox2/Ascl1. Genes used in the PCA are involved in neurotransmitter identity. Note the significant overlap between the two cell
populations, suggesting that expression of either Sox2/Neurog2 or Sox2/Ascl1/ may elicit similar neuronal phenotypes. (B) Heat map showing the relative expression
of 9 genes involved in the specification of different neuronal phenotypes. Observe the variable expression of genes essential for the specification of distinct
neurotransmitter identities in iNs derived from hUCMSCs lineage-converted through the expression of either Sox2/Neurog2 or Sox2/Ascl1. Choline O-acetyltransferase
(CHAT), Tyrosine hydroxylase (TH), Tryptophan hydroxylase 2 (TPH2), Vesicular Glutamate Transporter 1 (VGLUT1 or SLC17A7), GABA Vesicular Transporter (VGAT or
SLC32A1), FEZ family zinc finger 2 (FEZF2), T-box brain 1 (TBR1), SATB homeobox 2 (SATB2), COUP-TF-Interacting Protein 2 (CTIP2 or BCL11B).
of human pericytes into iNs using Sox2/Ascl1 (Karow et al.,
2012) and significantly higher than the conversion rate of human
fibroblasts into iNs using Ascl1 or Neurog2 alone (Chanda et al.,
2014; Gascón et al., 2016) or the combination Ascl1/Brn2/Myt1
(Caiazzo et al., 2011; Pang et al., 2011; Wapinski et al., 2013).
However, the latter can be increased by using micro-RNAs, co-
expression of Bcl-2 and small molecule treatment (Yoo et al.,
2011; Ladewig et al., 2012; Gascón et al., 2016).
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FIGURE 7 | Protein expression of vesicular transporters of lineage reprogrammed hUCMSC-derived iNs. Immunostaining for DSRED (red), GFP (green), vGAT (white;
left panel) or vGLUT1 (white; right panel) and DAPI (blue), 15 days post transfection (dpt). Scale bar represents 20µm. (A–H) hUCMSC transfected with control
plasmids encoding only reporter proteins GFP and DSRED. Note that cells displayed classical mesenchymal cell morphologies and did not express neither vGAT or
vGLUT1. (I–P) hUCMSC transfected with Sox2 and Ascl1. (Q–Y) hUCMSC transfected with Sox2 and Neurog2. (I,J) Observe the expression of the vesicular GABA
transporter (VGAT) in Sox2/Ascl1-derived iN (yellow arrows). The inset shows a high magnification view of the boxed area.
Single expression of Ascl1 is sufficient to convert other human
somatic cells into iNs (Chanda et al., 2014). This potential ofAscl1
is attributed to its ability to recognize and bind to the regulatory
elements of its target genes even when they are nucleosome-
bound (Wapinski et al., 2017). In contrast, the same pioneering
activity has not been shown to Neurog2, which is believed to
bind exclusively to accessible regulatory elements within the
genome. This could help to explain the prominent potential of
Neurog2 to lineage-reprogram astrocytes (Berninger et al., 2007;
Heinrich et al., 2010; Chouchane et al., 2017) and pluripotent
stem cells (Zhang et al., 2013) in comparison tomouse embryonic
fibroblasts into iNs (Gascón et al., 2016).
Our results indicate that a fraction of hUCMSCs (1–2%) has
an epigenetic state compatible with the binding of NEUROG2
to regulatory elements of neuronal genes, allowing for the
conversion into iNs. However, combination with Sox2, which
has a well-known role in chromatin modification of Neurog2-
target genes (Amador-Arjona et al., 2015), largely increases the
efficiency of neuronal conversion mediated by Neurog2 (∼35%).
Similarly, combination with Sox2 increases the percentage of
hUCMSCs converted by Ascl1 into iNs by an order of magnitude.
These observations suggest that key regulatory elements of
neuronal genes identified by ASCL1 and NEUROG2 are not
accessible in the vast majority of hUCMSCs cultured under the
conditions described in this study.
In addition to the low frequency of neuronal conversion
elicited in hUCMSC by forced expression of Ascl1 or Neurog2
alone, iNs also display electrophysiological properties less robust
compared to iNs generated using Sox2/Ascl1 or Sox2/Neurog2.
In fact, the action potential of iNs reprogrammed with a
single TF has a smaller amplitude and a shorter half-width
as compared to iNs reprogrammed with 2 TFs (Sox2/Ascl1
or Sox2/Neurog2), indicating that the latter express a more
complete set of ion channels. It is possible that these
differences represent a delay in the maturation of single-TF iNs.
Alternatively, the combination of Sox2/Ascl1 or Sox2/Neurog2
may be necessary to induce the complete transcriptional cascade
required for thorough neuronal maturation. Calcium transients
are implicated in distinct aspects of neuronal differentiation by
regulating neurotransmitter phenotype, dendritic morphology,
and axonal growth and guidance (Rosenberg and Spitzer,
2011). While control-transfected hUCMSCs never displayed
fast calcium transients, both Sox2/Ascl1- and Sox2/Neurog2-
iNs showed spontaneous fast calcium transients, indicative of
synaptic activity (Bonifazi et al., 2009). Likewise, the calcium
transients of primary neurons and iNs are synchronized,
suggesting that these cells are synaptically connected. Together,
these findings suggest that hUCMSCs are lineage-converted into
iNs capable of firing action potentials and establishing pre- and
post-synaptic compartments.
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The cellular and molecular mechanisms of direct lineage
reprogramming remain largely unknown. It has been reported
that the metabolic state is particularly important in direct
neuronal reprogramming of somatic cells into iNs. Accordingly,
co-expression of Bcl2/Neurog2 or Bcl2/Ascl1 greatly enhances
the conversion efficiency of astrocytes into iNs by inhibiting
lipid peroxidation, consistent with a caspase-independent role.
Similarly, co-expression of Bcl-2 alongside Ascl1 improves the
rates of lineage conversion of mouse embryonic fibroblast
into iNs, demonstrating that the metabolic shift is necessary
to support survival of lineage-converted iNs (Gascón et al.,
2016). Our data suggest that mouse astrocytes and hippocampal
neurons may contribute to enhance hUCMSCs survival during
lineage conversion. Future experiments should elucidate whether
Bcl2 co-expression or small molecules treatment would allow
for the conversion of Sox2/Neurog2- or Sox2/Ascl1-iNs from
hUCMSCs even in the absence of co-cultured cells.
Despite the large number of studies showing the conversion of
human somatic cells into iNs, it remains largely unknown what
is the phenotype of reprogrammed neurons (Ambasudhan et al.,
2011; Pang et al., 2011; Son et al., 2011; Karow et al., 2012; Chanda
et al., 2014; Hu et al., 2015). Moreover, it is still unclear whether
different TFs could induce particular neuronal fates in lineage-
converted cells. Here, we show that lineage-reprogrammed
hUCMSCs generate iNs expressing genes associated with the
acquisition of diverse neurotransmitter identities, regardless
of the use of Sox2/Ascl1 or Sox2/Neurog2. These different
combinations of TFs can regulate similar sets of genes,
suggesting that Sox2/Ascl1 and Sox2/Neurog2 are not sufficient
to drive unambiguous neurotransmitter identities in hUCMSCs-
derived iNs. However, the expression of genes associated
with a specific neuronal phenotype is only an indication
of the possible phenotype of the iNs. Future experiments
using electrophysiological and pharmacological techniques are
necessary to confirm the phenotypes of hUCMSCs-derived iNs.
According to the notion that Neurog2 and Ascl1 may be
sufficient to induce a pro-neuronal program during somatic
cell lineage reprogramming but not be sufficient to determine
a specific phenotype of the iN, studies of the developing
central nervous system reveal that those TFs may be associated
with diverse neuronal phenotypes. For instance, while in
the telencephalon, Neurog2 plays important roles for the
specification of glutamatergic neurons (Schuurmans and
Guillemot, 2002). Progenitors in the cerebellum and spinal cord
express Neurog2 generate GABAergic and cholinergic neurons,
respectively (Bertrand et al., 2002). Similarly, progenitors
expressing Ascl1 contribute to different neuronal lineages in
the cerebral cortex, cerebellum, and retina (Chouchane and
Costa, 2018). Most protocols aiming at obtaining fibroblast-
derived iNs with a particular phenotype through direct lineage
reprogramming require the use of several TFs (Victor et al., 2014;
Blanchard et al., 2015).
Expression of either Ascl1 and Neurog2 in cortical astrocytes
leads to the activation of transcriptional networks with only a
small subset of shared target genes (Masserdotti et al., 2015),
which could partly explain the role of those TFs in instructing
different iNs phenotypes (Berninger et al., 2007; Heinrich et al.,
2010). However, co-expression of Ascl1, Myt1L, and Brn2
induces a glutamatergic neuronal fate in fibroblast-derived iNs
(Vierbuchen et al., 2010), whereas Neurog2 drives motor neuron
differentiation associated with forskolin and dorsomorphin
treatments in the same cells (Liu et al., 2013), suggesting that
the fate-specification of iNs is not only dependent on the
TF used. Recent work in our laboratory using direct lineage
reprogramming of mouse astrocytes isolated from different brain
regions further supports the versatile roles of Neurog2 and
Ascl1 to affect the phenotypes of iNs (Chouchane et al., 2017).
While cerebral cortex astrocytes reprogrammed into iNs with
Neurog2 adopt mostly a glutamatergic fate, cerebellum astrocyte-
derived iNs show GABAergic phenotypes. Taken together, these
data indicate that the cell of origin with its specific epigenetic
landscape can influence the final fate of iNs.
A comprehensive understanding of the molecular
mechanisms involved in the acquisition of particular
neurochemical phenotypes will greatly improve the protocols for
lineage reprogramming of human somatic cells into iNs, allowing
for the generation of homogeneous neuronal populations that
could be later used in cell-based therapies.
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